Clinical trials
Completed Insulin Resistance trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese Medical Association | 3 |
| Eli Lilly and Company | 3 |
| Peking University Third Hospital | 2 |
| Sun Yat-sen University | 2 |
| AstraZeneca | 1 |
| Beijing Chao Yang Hospital | 1 |
| Beijing Sport University | 1 |
| Central South University | 1 |
| Chongqing Medical University | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 37 |
| Diabetes Mellitus, Type 2 | 10 |
| Diabetes Mellitus | 9 |
| Metabolic Diseases | 6 |
| Polycystic Ovary Syndrome | 5 |
| Critical Illness | 3 |
| Obesity | 3 |
| Glucose Metabolism Disorders | 2 |
| Autoimmune Diseases | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.